PRAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Pramine patents expire, and when can generic versions of Pramine launch?
Pramine is a drug marketed by Alra and is included in one NDA.
The generic ingredient in PRAMINE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pramine
A generic version of PRAMINE was approved as imipramine hydrochloride by STRIDES PHARMA on October 21st, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRAMINE?
- What are the global sales for PRAMINE?
- What is Average Wholesale Price for PRAMINE?
Summary for PRAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 179 |
| Patent Applications: | 1,056 |
| DailyMed Link: | PRAMINE at DailyMed |
US Patents and Regulatory Information for PRAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alra | PRAMINE | imipramine hydrochloride | TABLET;ORAL | 083827-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alra | PRAMINE | imipramine hydrochloride | TABLET;ORAL | 083827-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alra | PRAMINE | imipramine hydrochloride | TABLET;ORAL | 083827-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
